Harpoon Therapeutics Inc (HARP) Return on Investment ROI from the third quarter of 2023 to third quarter of 2022 and for the year 2023, average high and low, overall ranking from Sep 30 2023 to Sep 30 2022 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Harpoon Therapeutics Inc   (NASDAQ: HARP)


Harpoon Therapeutics Inc's ROI from its third quarter of 2023 to the third quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Harpoon Therapeutics Inc's ROI in the third quarter of 2023?
Harpoon Therapeutics Inc recorded a cumulative net loss of $-30 million during 12 months ending in the third quarter of 2023, resulting in a negative return on investment (ROI) of -111.54%.

Within the Healthcare sector 11 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Sep 30 2023 quarter, so far to 47, from total ROI ranking in the second quarter of 2023 at 75.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter
Y / Y Investment Change TTM -56.31 % -67.86 % -71.64 % -69.36 % -54.28 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 29 38 37 5 29
Return On Investment (TTM) -111.54 % -147.57 % -192.3 % -169.94 % -113.23 %
HARP's Overall Ranking # 47 # 75 # 1333 # 77 # 82
Seq. Investment Change TTM 0.03 % -10.53 % -23.35 % -36.32 % -26.41 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -30 -40 -59 -68 -71

HARP Company Profile >> Back to HARP Roi Comparisons >> See Annual HARP Return On Investment



Return On Investment HARP's Ranking
Within: No.
Industry # 4
Sector # 12
Overall # 47

Return On Investment Statistics
High Average Low
91.85 %
10.2 %
-41.36 %
(Sep 30 2023)   (Sep 30 2021)







Financial Statements
Harpoon Therapeutics Inc's III. Quarter Investments $ 29 Millions HARP's Balance sheet
Harpoon Therapeutics Inc's III. Quarter Income $ -2 Millions Quarterly HARP's Income Statement
HARP's Income by Division See HARP's Income by Division


HARP Annual Return On Investment (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2016)
2018
Total Investments in Millions 5 124 94 53 0
Y / Y Investment Growth -95.63 % 31.26 % 77.46 % - -
Net Income in Millions -68 -117 -50 -56 -11
Y / Y Net Income Growth - - - - -
Annual Return On Investment -1254.51 % -94.38 % -52.97 % -104.67 % -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
HARP's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for HARP's Competitors
Subscribers only: Roi for Harpoon Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for HARP's Customers

Other Ratios
HARP's Roa HARP's Inventory Turnover Ratio HARP's Growth Rates HARP's Dividend Statistics
HARP's Profitability Ratios HARP's Asset Turnover Ratio HARP's Dividend Growth
HARP's Roe HARP's Valuation Ratios HARP's Financial Strength Ratios HARP's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2023, within Healthcare Sector ROI

Date modified: 2026-08-29T17:40:15+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.